Osteoarthritis Therapeutics Market 2025 to 2034
Osteoarthritis Therapeutics Market 2025 to 2034
Osteoarthritis Therapeutics Market (By Drugs: Non-steroidal Anti-inflammatory Drugs (NSAIDs), Viscosupplementation Agents, Corticosteroids, Hyaluronic Acid Injection, Analgesics; By Anatomy: Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, Others; By Purchasing Pattern: Prescription Drugs, Over-the-counter Drugs; By Distribution Channel: Hospital Pharmacies, Hypermarket & Supermarket, Online Pharmacies, Retail Pharmacies, Others; By Route of Administration: Parenteral Route, Topical Route, Oral Route; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 10.84 Bn
Forecast Year, 2035
USD 26.31 Bn
CAGR, 2025 - 2035
9.27
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global osteoarthritis therapeutics market is poised for significant growth, valued at USD 41.13 billion in 2025 and expected to reach USD 26.31 billion by 2035, expanding at a CAGR of 9.27%, driven by rising prevalence and treatment demand.
Osteoarthritis Therapeutics Market Size Analysis
Osteoarthritis Therapeutics Market Size By Drugs 2025 to 2034 (USD Billion)
| Drugs | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-steroidal Anti-inflammatory Drugs (NSAIDs) | 0.73 | 0.80 | 0.87 | 0.95 | 1.03 | 1.13 | 1.24 | 1.36 | 1.47 | 1.61 |
| Viscosupplementation agents | 1.45 | 1.57 | 1.72 | 1.89 | 2.07 | 2.25 | 2.46 | 2.70 | 2.94 | 3.22 |
| Corticosteroids | 2.16 | 2.38 | 2.58 | 2.82 | 3.09 | 3.38 | 3.70 | 4.04 | 4.39 | 4.81 |
| Hyaluronic Acid Injection | 2.88 | 3.15 | 3.46 | 3.77 | 4.12 | 4.50 | 4.91 | 5.38 | 5.88 | 6.42 |
| Analgesics | 3.61 | 3.95 | 4.31 | 4.71 | 5.15 | 5.62 | 6.14 | 6.69 | 7.35 | 8.01 |
Osteoarthritis Therapeutics Market Size By Anatomy 2025 to 2034 (USD Billion)
| Anatomy | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ankle Osteoarthritis | 0.73 | 0.80 | 0.86 | 0.94 | 1.04 | 1.13 | 1.24 | 1.36 | 1.49 | 1.62 |
| Hip Osteoarthritis | 1.45 | 1.58 | 1.73 | 1.89 | 2.06 | 2.26 | 2.46 | 2.70 | 2.95 | 3.20 |
| Knee Osteoarthritis | 2.17 | 2.36 | 2.59 | 2.82 | 3.10 | 3.37 | 3.69 | 4.02 | 4.39 | 4.83 |
| Shoulder Osteoarthritis | 2.89 | 3.16 | 3.45 | 3.78 | 4.11 | 4.49 | 4.92 | 5.36 | 5.87 | 6.42 |
| Others | 3.60 | 3.95 | 4.31 | 4.70 | 5.14 | 5.62 | 6.15 | 6.72 | 7.33 | 8.01 |
Osteoarthritis Therapeutics Market Size By Purchasing Pattern 2025 to 2034 (USD Billion)
| Purchasing Pattern | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Prescription Drugs | 3.61 | 3.96 | 4.32 | 4.71 | 5.17 | 5.65 | 6.20 | 6.79 | 7.42 | 8.09 |
| Over-the-counter Drugs | 7.23 | 7.88 | 8.62 | 9.43 | 10.28 | 11.24 | 12.25 | 13.38 | 14.61 | 15.98 |
Osteoarthritis Therapeutics Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 0.73 | 0.80 | 0.87 | 0.95 | 1.04 | 1.14 | 1.23 | 1.36 | 1.49 | 1.62 |
| Hypermarket & Supermarket | 1.45 | 1.57 | 1.73 | 1.89 | 2.07 | 2.25 | 2.47 | 2.70 | 2.93 | 3.23 |
| Online Pharmacies | 2.17 | 2.37 | 2.59 | 2.83 | 3.08 | 3.37 | 3.69 | 4.03 | 4.41 | 4.80 |
| Retail Pharmacies | 2.89 | 3.16 | 3.46 | 3.76 | 4.12 | 4.50 | 4.92 | 5.37 | 5.86 | 6.42 |
| Others | 3.61 | 3.94 | 4.31 | 4.71 | 5.14 | 5.62 | 6.15 | 6.71 | 7.34 | 8.01 |
Osteoarthritis Therapeutics Market Size By Route of Administration 2025 to 2034 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Parenteral Route | 1.81 | 1.99 | 2.16 | 2.34 | 2.57 | 2.82 | 3.07 | 3.37 | 3.72 | 4.01 |
| Topical Route | 3.62 | 3.94 | 4.30 | 4.73 | 5.14 | 5.65 | 6.15 | 6.72 | 7.31 | 8.02 |
| Oral Route | 5.41 | 5.91 | 6.47 | 7.07 | 7.74 | 8.41 | 9.23 | 10.07 | 11.00 | 12.05 |
Osteoarthritis Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.09 | 1.19 | 1.30 | 1.43 | 1.57 | 1.69 | 1.87 | 2.01 | 2.20 | 2.43 |
| LAMEA | 2.17 | 2.36 | 2.59 | 2.83 | 3.08 | 3.38 | 3.68 | 4.06 | 4.42 | 4.80 |
| Europe | 3.25 | 3.56 | 3.87 | 4.23 | 4.62 | 5.06 | 5.53 | 6.05 | 6.59 | 7.24 |
| Asia-Pacific | 4.33 | 4.73 | 5.18 | 5.65 | 6.18 | 6.75 | 7.38 | 8.04 | 8.82 | 9.61 |
Osteoarthritis Therapeutics Market Size to Hit USD 26.31 Billion by 2035
The global osteoarthritis therapeutics market size is estimated at USD 41.13 billion in 2025 and is projected to be worth around USD 26.31 billion by 2035 with a growing at a CAGR of 9.27%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
